Where the pathway breaks — and how we close it
Vendor builds clinical software without carrying a caseload
Most patient-engagement platforms are designed by product managers who have never sat with a patient on a Tuesday afternoon between two appointments. The dashboards are pretty. The clinical workflows do not survive contact with real practice. Clinicians flag the gaps in support tickets that get triaged behind the next feature release.
Cost when unaddressed: Workflows that fail in clinical reality fail downstream — on the tenant. Clinical directors discover the broken handoffs after they have signed the contract and enrolled the first patients.
Founder is the first user
Matthew Sexton, LCSW carries a real fee-for-service caseload across four state licenses (New York, Maine, Florida, Delaware). Every shipping decision passes through the lens of a licensed clinician with twelve patients on the schedule. Workflows that fail on the founder's caseload get killed before any tenant sees them.
Measurement-based-care theater — assessments nobody scores
Most platforms ship measurement-based-care as a checkbox feature. The PHQ-9 fires. The patient completes it. The score lands in a database column nobody opens. The clinician walks into the next session blind to the trend, because the dashboard surface is two clicks deep and gated behind a workflow nobody set up.
Cost when unaddressed: Clinicians lose the early-warning signal. A patient declining over three weeks looks fine in session because the trend never crossed the clinician's eye. Symptom escalation goes undetected.
PHQ-9 / GAD-7 / C-SSRS scored, trended, surfaced inside the session note
The platform auto-serves PHQ-9 and GAD-7 on a weekly cadence, scores against clinical thresholds, trends across the active episode of care, and surfaces inside both the patient view and the clinician view with delta-from-baseline coloration. C-SSRS column scoring fires CRISIS_FLAG when ideation thresholds cross. The pre-session digest lands in the clinician inbox two hours before every appointment with the trend already drawn.
Crisis routing is opt-in instead of default-on
Most patient-engagement platforms treat 988 routing and safety-plan workflows as a premium add-on. Tenants must enable them. Clinical directors must read documentation. By the time the routing is wired, a CRISIS_FLAG has fired and nobody knew the route was off.
Cost when unaddressed: When a patient escalates and the routing is unconfigured, the platform fails the patient at the moment that mattered most. The vendor blames the tenant for not enabling the feature. The patient does not get a second chance.
988 single-tap + Stanley-Brown safety planning default-on
Every tenant ships with 988 single-tap routing live from day one and Stanley-Brown safety planning available inside the patient view. C-SSRS column scoring fires CRISIS_FLAG, the escalation surfaces inside the platform with a timestamped audit trail, and route closure is measured per event. No tenant configuration required to make the safety baseline live.
Telehealth ghost rate between session 1 and session 2
Telehealth practices lose roughly half of new patients between intake and session two. The intake call is warm. The forms are completed. Then the patient never returns. The pattern is so common that most clinicians have stopped tracking it — the loss is treated as a fact of practice instead of a workflow problem.
Cost when unaddressed: Half of every clinician's intake hours funnel patients who will not return. Clinical capacity wastes on warm-up that produces no continuity of care. The patient does not get the help they came for.
Daily check-in scaffold + onboarding gamification across days 1-7
The platform's daily check-in scaffold establishes a working alliance digitally before session two. Onboarding gamification across the first seven days — micro check-ins, between-session journaling prompts, an in-app safety plan workflow, and a measurement-based-care assessment delivered before session two — converts ghost rate into retained engagement.
FHIR R4 export gated behind enterprise-tier paywalls
Most patient-navigation platforms paywall FHIR R4 export behind the highest enterprise tier. Solo practices and small group practices that need to coordinate with primary care providers cannot afford the upgrade. The result is care-team fragmentation — the therapy record stays trapped inside the engagement platform while the PCP works without context.
Cost when unaddressed: PCPs make medication decisions without therapy context. Therapists make session decisions without medical context. Patients shuttle their own care coordination across mismatched portals.
FHIR R4 export ships on every tier from Solo upward
FHIR R4 patient-consented export is a tier-zero feature. Available on Solo, Practice, Group, and Enterprise — never paywalled. PCP coordination round-trips, downstream EHR ingestion, and care-team handoff all supported with patient consent gated at export time and a tamper-evident audit-trail entry written before the bundle leaves the tenant boundary.
Vendor distance — workflows fail downstream on tenants
When the vendor product team has never carried a clinical caseload, the broken workflows surface on the tenant first. Tenants discover the gaps after deploy. The vendor opens a support ticket queue. The fix lands six months later in a feature release. The tenant absorbs the operational cost in the meantime.
Cost when unaddressed: Tenant clinical directors burn out on workflow workarounds. The platform compliance posture degrades. Support-ticket SLA replaces clinical-fit SLA as the operational metric of record.
Founder absorbs the dogfood cost — tenants inherit a sanded platform
Workflows that fail in clinical reality fail on the founder first. A broken check-in surface, a missed CRISIS_FLAG, a slow pre-session digest, a measurement-based-care assessment that never gets scored, a 988 routing handoff that drops on a Friday night — the founder sees it before any tenant does. Founding customers inherit a platform whose rough edges have already been sanded down by the clinician selling it.
Methodology
How we measure
The founder's clinical practice — Matthew Sexton, LCSW, PLLC — operates as the platform's first tenant in production. Every workflow shipped to an external tenant has cleared six explicit dogfood checkpoints on a real, licensed, fee-for-service clinical caseload first. The methodology decomposes into six control families: BAA scope executed under PLLC entity, pgcrypto column-level encryption verified, weekly Wednesday HIPAA gate baseline (43 PASS / 0 WARN / 0 FAIL), FHIR R4 export proven on real consented records, CRISIS_FLAG escalation route closure audit, and the no-PHI-in-GitHub policy enforced by the BAA-covered AWS boundary. Aggregate metrics — digital intake completion rate, session-2 attendance lift, pre-session digest delivery time, CRISIS_FLAG closure rate — are reportable as HIPAA-safe operational measurements that travel without identifying any patient.
What counts
- PLLC tenant operating in production with real fee-for-service patients
- BAA executed under PLLC entity for Vertex AI, AWS, and Amazon RDS
- pgcrypto column-level encryption on PHI columns verified in live config
- Weekly Wednesday HIPAA gate baseline 43 PASS / 0 WARN / 0 FAIL — PLLC tenant included in scope
- FHIR R4 patient-consented export exercised on real records before tenant ship
- CRISIS_FLAG escalation events with timestamped audit trail and SLA closure metric
- Stanley-Brown safety planning workflow exercised inside the founder's caseload
What doesn't count
- Synthetic patient fixtures used as a substitute for real clinical exposure
- Sandbox demo tenants with no licensed clinical caseload behind them
- Paid pilot programs that the vendor underwrites to claim a customer count
- Marketing-only logos with no executed BAA, no production tenant, no clinical workflow
- Workflows that bypass the weekly Wednesday HIPAA gate on the founder tenant
How we compare
Sourced from primary citations — not vendor marketing claims.
| Us MWS Inc. (founder is first user) | vs Vendor with no clinical caseload | vs Paid-pilot vendor (sandbox demo) | vs Logo-only marketing claim | |
|---|---|---|---|---|
| Licensed clinician on the product team cite | Yes — founder + LCSW carrying caseload across 4 states | No | No | No |
| First tenant in production cite | Founder's own PLLC clinical practice | Sandbox demo tenant | Paid pilot underwritten by vendor | Marketing logo without executed BAA |
| BAA executed before workflow ships cite | Vertex AI + AWS + RDS — under PLLC entity | Often partial | Tenant-specific paperwork delays | Marketing claim only |
| FHIR R4 export availability cite | Tier-zero — every tier from Solo upward | Enterprise paywall | Pilot-tier only | Not implemented |
| Crisis routing posture cite | 988 + Stanley-Brown default-on every tenant | Opt-in add-on | Pilot scope only | Marketing language |
| Weekly HIPAA gate cadence cite | 43-control gate every Wednesday — PLLC tenant in scope | Annual risk analysis | Pre-deploy only | Compliance check on demand |
| Workflow QA discovery point cite | Founder caseload pre-tenant ship | Tenant after deploy | Pilot tenant absorbs | Customer-support backlog |
Frequently asked questions
- How many paying customers does the platform have today?
- Founder-credibility frame, transparent: the platform is pre-revenue on every product line except the founder's own clinical practice. The first deployment is Matthew Sexton, LCSW, PLLC — a real, licensed, fee-for-service therapy practice that runs on the same software being sold. The vendor builds it, the vendor uses it, the vendor ships it. Founding-customer pricing is open to the first cohort of clinics and practices that engage before public pricing launches. Public dollar-amount pricing is paused on every public surface until the LLM cost combo and Mr Whiskers viability prove out — discovery calls scope founding-customer terms directly with the founder.
Cited: google-cloud-2024-vertex-ai-baa , aws-2024-hipaa-eligible-services
- Why is the founder's own practice the first case study?
- A platform that captures patient-engagement data, runs measurement-based-care assessments, escalates crisis flags, and exports FHIR R4 records cannot be honestly sold by a vendor that has never carried a clinical caseload on it. Building software for clinicians while practicing as a clinician is the credibility frame — the founder eats his own cooking. Every workflow proven on the founder's clinical caseload before it ships to a tenant. The PLLC carries fee-for-service patients across four state licenses, and the platform is the operational substrate of the practice — not a pilot, not a sandbox.
Cited: fda-2022-software-medical-device-guidance , apa-2023-practitioner-pulse-survey
- What numbers can you actually share without exposing PHI?
- HIPAA-safe aggregate metrics only. Numbers like the percentage of intakes that complete digital onboarding before session one, the percentage that attend session two, the average pre-session digest delivery time, the count of CRISIS_FLAG events that escalated and resolved inside SLA — these are reportable without identifying any patient. Patient names, identifiers, session content, dates of birth, addresses, and clinical free-text are never published, never quoted in marketing, never pasted into chat. PHI lives in BAA-covered AWS only. The no-PHI-in-GitHub rule is unbreakable and applies to every artifact this team ships.
Cited: hhs-45-cfr-164-312-technical-safeguards , nist-2017-sp-800-66-hipaa-implementation
- When will external customer logos appear on this page?
- When founding customers consent in writing to a logo placement. The platform is in founding-customer engagement mode until the public pricing ladder launches. Founding-customer logo policy is agreed during the discovery call — most clinics prefer to wait until they have eight to twelve weeks of tenant data before consenting to public attribution, which is the right answer. Marketing-only logos with no executed BAA and no production tenant do not count as customers, and this page will never carry them.
Cited: hhs-2013-hipaa-omnibus-rule
- What does a founding-customer engagement look like?
- Thirty-minute discovery call directly with the founder. Tenant fit assessment. Letter of Intent. BAA execution under the tenant's scope. Forty-eight-hour tenant turn-up — branding, DNS, admin onboarding, patient enrollment workflow. Founding-customer terms lock for the life of the contract. No SDR, no sales engineer, no qualification scripts, no junior account executive booking the next call. The founder runs the engagement end to end until the platform earns the right to staff the role. The 48-hour clock is the architecture, not a sales claim — the BAA chain, the white-label tokens, and the tenant provisioning sequence support it.
Cited: onc-2024-hti-1-final-rule , google-cloud-2024-vertex-ai-baa
- What happens to founding-customer pricing when public pricing launches?
- Founding-tier pricing locks for the life of the contract. Public pricing changes on the marketing site do not flow through to founding-customer terms. The economic logic is straightforward — early customers carry the proof-burden alongside the founder, and the platform recognizes that contribution by holding the founding-tier price flat against future increases. Direct-line founder access, quarterly product roadmap review, and tenant-specific BAA scope inside 48 hours are all part of the founding-customer covenant.
Why this exists
The vendor builds the platform. The vendor uses the platform. The vendor ships the platform. The founder eats his own cooking, and founding customers inherit the sanded surface.
Matthew Sexton, LCSW Founder · Mental Wealth Solutions Inc.
Citations
- (2024). HIPAA Compliance on Google Cloud — Business Associate Agreement and Covered Services. Google Cloud.
Source
- Google Cloud offers Business Associate Agreement (BAA) coverage for Vertex AI services including Gemini API (text-bison, gemini-pro, gemini-1.5-pro, gemini-1.5-flash) — establishing HIPAA-compliant LLM infrastructure for covered entities and business associates.
- BAA-covered Vertex AI services include: Gemini API for text generation, Embeddings API, Vector Search, Vertex AI Pipelines, Vertex AI Workbench, AutoML, Model Registry, Model Monitoring, and Endpoints — comprehensive ML/AI infrastructure for HIPAA-regulated workflows.
- Established the BAA-covered LLM cloud infrastructure baseline that enables HIPAA-compliant deployment of large-language-model clinical applications without requiring on-premise model hosting — key infrastructure enabling cloud-native HIPAA AI architecture.
“Google Cloud Vertex AI BAA coverage includes the full Gemini API family plus Embeddings, Vector Search, AutoML, and Model Endpoints — establishing the BAA-covered LLM cloud infrastructure baseline for HIPAA-compliant clinical AI deployment.”
- (2024). HIPAA Eligible Services Reference. Amazon Web Services.
Source
- AWS HIPAA Eligible Services Reference documents the comprehensive list of AWS services covered under the AWS BAA — currently 175+ services including EC2, RDS, S3, KMS, Lambda, Bedrock, SageMaker, CloudWatch Logs, Systems Manager, and Aurora.
- Critical HIPAA-architecture services for healthcare workloads: RDS (encrypted PostgreSQL/MySQL with pgcrypto), S3 with SSE-KMS encryption, Bedrock for LLM inference (BAA-covered foundation models), Systems Manager Session Manager (CloudTrail-logged session-data S3 archival), and CloudWatch Logs for audit trail.
- Established the AWS BAA-covered services baseline enabling HIPAA-compliant cloud-native architecture for healthcare workloads — key infrastructure enabling HIPAA-compliant deployment without requiring on-premise hosting or self-hosted security infrastructure.
“AWS HIPAA Eligible Services covers 175+ services under BAA including RDS, S3, Bedrock, SageMaker, and Systems Manager Session Manager — establishing the AWS BAA-covered services baseline for HIPAA-compliant cloud-native healthcare architecture.”
- (2013). Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules — Omnibus Rule. HHS Office for Civil Rights.
Source
- HHS HIPAA Omnibus Rule (effective March 2013) implementing HITECH Act provisions — established business-associate direct liability for HIPAA violations, expanded breach notification requirements, and updated marketing/fundraising restrictions.
- Established that business associates (including health-IT vendors and cloud-service providers handling ePHI) are directly liable for HIPAA Security Rule and Breach Notification Rule violations — extending HIPAA enforcement to the entire ePHI handling chain rather than only covered entities.
- Anchored the modern HIPAA enforcement framework: covered entities and business associates each carry direct compliance obligations, with Business Associate Agreements (BAAs) as the contractual instrument establishing the compliance chain.
“The 2013 HIPAA Omnibus Rule established business-associate direct liability for HIPAA violations — extending enforcement to the entire ePHI handling chain with Business Associate Agreements as the contractual compliance instrument.”
- (2013). HIPAA Security Rule — Technical Safeguards (45 CFR § 164.312). Code of Federal Regulations, Title 45 — Public Welfare.
Source
- Mandates access control, audit controls, integrity controls, person-or-entity authentication, and transmission security as technical safeguards for ePHI.
- Encryption and decryption are addressable specifications under access control and transmission security — required unless an alternative measure is documented as equally protective.
- Audit controls require hardware, software, and procedural mechanisms to record and examine activity in systems containing or using ePHI.
“A covered entity or business associate must implement technical policies and procedures for electronic information systems that maintain electronic protected health information to allow access only to those persons or software programs that have been granted access rights.”
- (2024). NIST Special Publication 800-66 Revision 2 — Implementing the Health Insurance Portability and Accountability Act (HIPAA) Security Rule. National Institute of Standards and Technology.
Source
- NIST SP 800-66 Rev. 2 (February 2024) provides authoritative implementation guidance for HIPAA Security Rule technical, administrative, and physical safeguards — referenced by HHS OCR as definitive HIPAA Security Rule implementation reference.
- Establishes detailed technical-safeguards implementation guidance: access control, audit controls, integrity controls, person/entity authentication, transmission security, and encryption — with cross-references to NIST Cybersecurity Framework and NIST SP 800-53 security controls.
- Anchored the federally-recognized HIPAA Security Rule implementation framework — covered entities and business associates following NIST SP 800-66 implementation guidance establish a defensible technical-safeguards posture.
“NIST SP 800-66 Rev. 2 provides authoritative HIPAA Security Rule implementation guidance — referenced by HHS OCR as definitive technical-safeguards implementation reference, anchoring federally-recognized HIPAA security architecture.”
- (2024). Health Data, Technology, and Interoperability — Certification Program Updates, Algorithm Transparency, and Information Sharing (HTI-1) Final Rule. HHS ONC.
Source
- ONC HTI-1 Final Rule (January 2024) establishes the first federal regulatory framework for AI/algorithm transparency in certified health IT — including 'Decision Support Interventions' (DSI) certification criteria for predictive AI/machine-learning models embedded in EHRs.
- DSI certification requires source attribute disclosure for predictive models, intervention risk management practices, and feedback mechanism for end users — establishing the baseline transparency requirements for AI-enabled clinical decision support.
- Anchored the regulatory baseline for AI in certified health IT — vendors offering AI/ML-enabled clinical decision support to ONC-certified EHRs must satisfy DSI transparency and risk-management requirements as of January 1, 2025 effective date.
“ONC HTI-1 Final Rule establishes the first federal regulatory framework for AI/algorithm transparency in certified health IT — DSI certification requires source attribute disclosure, intervention risk management, and end-user feedback mechanisms for predictive AI/ML models.”
- (2022). Clinical Decision Support Software — Guidance for Industry and Food and Drug Administration Staff. U.S. Food and Drug Administration.
Source
- FDA Clinical Decision Support Software guidance (September 2022) clarifies which CDS software functions qualify as medical devices subject to FDA regulation under the 21st Century Cures Act.
- FDA-regulated CDS includes software that: provides diagnostic/treatment recommendations not based on transparent rationale clinicians can independently review, processes medical images/signals/patterns, or provides time-critical decisions where clinicians cannot independently review rationale — requiring premarket FDA review.
- Anchored the FDA medical-device regulatory boundary for clinical AI software — AI/ML systems providing autonomous diagnostic/treatment recommendations cross into FDA-regulated medical-device territory, while non-autonomous reference/educational tools remain non-device.
“FDA's CDS Software guidance clarifies the medical-device regulatory boundary for clinical AI — autonomous diagnostic/treatment recommendation systems cross into FDA-regulated medical-device territory, while non-autonomous reference tools remain non-device.”
- (2025). CCBHC Quality Measure Set and Reporting Requirements. U.S. Department of Health and Human Services / CMS.
Source
- CMS-defined quality measure set required for CCBHC participation in the Medicaid Section 223 demonstration and state-option Medicaid CCBHC programs.
- Required measures include depression remission at 12 months, follow-up after hospitalization for mental illness (FUH), screening for clinical depression and follow-up plan, and adherence to antipsychotic medications for schizophrenia.
- Quality-measure performance directly drives CCBHC prospective payment system rate cells and continued certification eligibility.
“CMS quality-measure performance directly drives CCBHC payment rate cells and certification eligibility, making measurement-based care reporting infrastructure a financial as well as clinical requirement.”
- (2021). Screening for depression in primary care with Patient Health Questionnaire-9 (PHQ-9): a systematic review. Journal of Affective Disorders.
doi:10.1016/j.jad.2020.09.131
- Systematic review pooled diagnostic performance data on PHQ-9 from 36 primary-care studies covering more than 28,000 patients across 18 countries.
- PHQ-9 cutoff of 10 yielded a pooled sensitivity in the 80% range and pooled specificity in the 80% to 90% range for major depressive disorder, supporting its use as a primary-care screening instrument.
- Performance was robust across age groups, ethnicities, and primary-care settings, though specificity dropped in populations with high rates of somatic illness due to symptom overlap.
“The PHQ-9 demonstrates acceptable diagnostic accuracy as a screening tool for major depression in adult primary-care populations, with cutoff scores of 10 or above offering an evidence-based threshold for further evaluation.”
- (2011). The Columbia–Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. American Journal of Psychiatry.
doi:10.1176/appi.ajp.2011.10111704
- Validation of the Columbia-Suicide Severity Rating Scale (C-SSRS) across three multisite studies including adolescents and adults presenting in clinical and research settings.
- C-SSRS demonstrated strong predictive validity for future suicidal behavior and supported real-time suicide-risk stratification in emergency, inpatient, and outpatient contexts.
- Established the standardized suicide-risk assessment instrument now embedded in CCBHC suicide-care pathways and Joint Commission expectations.
“The Columbia-Suicide Severity Rating Scale provides a reliable, structured framework for stratifying suicide risk that has become the de facto standard for behavioral health and emergency department screening.”
- (2012). Safety planning intervention: a brief intervention to mitigate suicide risk. Cognitive and Behavioral Practice.
doi:10.1016/j.cbpra.2011.01.001
- Original description of the Safety Planning Intervention (SPI), a brief structured collaborative protocol for individuals at risk of suicide developed for emergency, primary care, and behavioral health settings.
- SPI components include warning sign identification, internal coping strategies, social contacts and settings that distract, family/friend contacts, professional contacts, and means restriction counseling.
- Established the standardized evidence-based safety planning protocol now adopted as the de facto national standard across CCBHCs, EDs, VA systems, and Joint Commission-accredited programs.
“The Safety Planning Intervention provides a brief, structured, collaborative protocol that has become the national evidence-based standard for suicide-risk mitigation across emergency, primary care, and behavioral health settings.”
- (2018). Comparison of the Safety Planning Intervention with follow-up vs usual care of suicidal patients treated in the emergency department. JAMA Psychiatry.
doi:10.1001/jamapsychiatry.2018.1776
- Cohort comparison study of 1,640 suicidal patients across 9 emergency departments comparing the Safety Planning Intervention plus structured follow-up phone outreach with usual care.
- Intervention arm showed a 45% reduction in suicidal behaviors over 6 months compared with the usual-care comparison group.
- Engagement in outpatient mental-health treatment was approximately twice as high in the intervention arm relative to usual care.
“The Safety Planning Intervention combined with structured telephone follow-up was associated with a substantial reduction in suicidal behavior and increased outpatient treatment engagement among emergency-department patients.”
- (2023). 2023 Practitioner Pulse Survey. American Psychological Association.
Source
- APA Practitioner Pulse Survey of licensed psychologists documenting workload, telehealth adoption, waitlist length, and burnout indicators across U.S. practice settings.
- Majority of surveyed psychologists report sustained increase in demand for services post-pandemic, with significant proportions reporting waitlists for new patient intake.
- Telehealth adoption among practicing psychologists has stabilized at substantially elevated levels relative to pre-pandemic baseline, with hybrid practice models becoming the dominant operational pattern.
“APA Practitioner Pulse Survey data document sustained post-pandemic demand pressure and stabilization of telehealth-enabled hybrid practice as the dominant operational model among U.S. licensed psychologists.”
- (2005). Work setting and burnout among professional psychologists. Professional Psychology: Research and Practice.
doi:10.1037/0735-7028.36.5.544
- Cross-sectional survey of licensed psychologists across solo private, group private, and agency settings examining burnout dimensions (emotional exhaustion, depersonalization, personal accomplishment) by work-setting type.
- Solo and group private-practice psychologists reported significantly lower emotional exhaustion and higher personal accomplishment than agency-setting peers, with managed-care administrative burden a primary moderator.
- Work-setting autonomy and control over caseload composition emerged as the primary protective factors against psychologist burnout in regression models.
“Solo and group private-practice psychologists report significantly lower emotional exhaustion and higher personal accomplishment than agency-setting peers, with autonomy and caseload control as the primary protective factors against burnout.”
- (2015). Preventing burnout: What does the research tell us?. Professional Psychology: Research and Practice.
doi:10.1037/a0039297
- Synthesis of empirical research on protective factors and intervention strategies for preventing burnout among professional psychologists across practice settings.
- Identified three core protective domains: structural workplace factors (autonomy, caseload control, schedule flexibility), interpersonal supports (supervision, peer consultation), and personal-care behaviors (boundary-setting, replenishment activities).
- Burnout-prevention interventions targeting structural workplace factors yielded larger effect sizes than interventions focused exclusively on individual self-care strategies.
“Burnout-prevention interventions targeting structural workplace factors — autonomy, caseload control, schedule flexibility — yielded larger effect sizes than interventions focused exclusively on individual self-care strategies.”
- (2024). HEDIS Measures: Follow-Up After Hospitalization for Mental Illness and Initiation and Engagement of Substance Use Disorder Treatment. National Committee for Quality Assurance.
Source
- NCQA HEDIS quality measures defining the industry-standard expectations for follow-up after psychiatric hospitalization (FUH) and substance use disorder treatment initiation and engagement (IET).
- Health-plan performance on FUH and IET HEDIS measures directly impacts NCQA accreditation, Medicare Advantage Star Ratings, and Medicaid managed care quality reporting.
- Establishes the industry-standard quality-measurement framework that anchors closed-loop referral and engagement expectations across health plan, ACO, and EAP delivery channels.
“NCQA HEDIS quality measures for follow-up after psychiatric hospitalization and substance use treatment engagement define the industry-standard quality framework that anchors closed-loop referral and engagement expectations across health plan and EAP delivery channels.”